DMPA: Clinical Trials

20 trials of DMPA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 2 unknown, 1 withdrawn. 7 Phase 4, 5 Phase 2, 3 Early Phase 1, 3 Phase 1, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 47Completed 6, Unknown 1
Phase 25Completed 4, Unknown 1
Early Phase 13Completed 3
Phase 13Completed 2, Withdrawn 1
Not applicable2Completed 2

Follow DMPA: new trials by email Literature Review of DMPA trials Research Report on DMPA

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: A Pilot Study
Depo Medroxyprogesterone acetate - Postpartum Contraception, Depot Medroxyprogesterone Acetate
Phase 4CompletedUniversity of California, San Diego402025-03-262025-09-10
Endometrial Biopsy in Progestin Contraceptive Users
DMPA, Etonogestrel implant - Contraception
Early Phase 1CompletedOregon Health and Science University592023-07-012026-10-14
BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study
B/F/TAF, TDF/3TC/EFV or DTG or NVP, DMPA - Bone Loss
Phase 4UnknownMU-JHU CARE3302019-12-032023-04-07
The Kampala Women's Bone Study
FTC/TDF and DMPA, FTC/TDF, DMPA - Bone Demineralization, Hypoestrogenism
Phase 4CompletedUniversity of Washington5002018-05-152024-06-17
Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health Workers
DMPA, Sayana Press - Contraception
Early Phase 1CompletedFHI 3604602018-03-192021-04-13
Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP
tenofovir/emtricitabine, DMPA - HIV/AIDS, Contraception
Early Phase 1CompletedSharon Achilles152017-11-172020-12-03
The Evidence for Contraceptive Options and HIV Outcomes Trial
DMPA, LNG, Copper IUD - HIV, Contraception
Not applicableCompletedFHI 36078302015-12-142019-08-20
PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB
Depot medroxyprogesterone acetate - HIV-1 Infection, Tuberculosis
Phase 2CompletedAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections622015-11-032019-07-01
Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
LNG-IUS, DMPA - Endometriosis
Phase 4CompletedKing Chulalongkorn Memorial Hospital502015-06-012017-03-17
The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy
Depot medroxyprogesterone acetate, Placebo - Grade 1 Endometrial Endometrioid Adenocarcinoma, Grade 2 Endometrial Endometrioid Adenocarcinoma
Phase 2UnknownWomen and Infants Hospital of Rhode Island762015-02-012016-09-20
Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women
Depo-Medroxyprogesterone Acetate, Progestin Contraceptive (Jadelle) - HIV, Contraception
Phase 4CompletedCenters for Disease Control and Prevention1312014-04-082018-03-19
HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC
DMPA, NET-EN, MPA/E2 - Contraception, HIV
CompletedUniversity of Pittsburgh4512014-02-012020-12-03
Long-Acting Reversible Contraception
DMPA, oral contraceptives, Implanon® - Contraception
Phase 4CompletedFHI 3609162011-12-012018-02-28
Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
Depot medroxyprogesterone acetate - Contraception, Postpartum Depression
Phase 4CompletedBeatrice Chen1842011-11-012018-08-31
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
depo-medroxyprogesterone acetate - HIV-1 Infection
Phase 2CompletedAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections252011-05-012015-12-22
Same-day Long-acting Reversible Contraception for Medication Abortion
DMPA, Etonogestrel implant - Abortion; Induced
CompletedBoston University402011-05-012017-04-07
Depot Contraception With and Without Lopinavir/Ritonavir
DMPA - HIV Infection
Phase 1WithdrawnSt Stephens Aids Trust102010-12-012010-11-29
Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi
Copper IUD, Depo Medroxyprogesterone acetate - HIV
Not applicableCompletedEmory University2002010-07-012013-10-25
Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum
Acyline, Testosterone Gel, Depo-Medroxyprogesterone - Contraception
Phase 1 / Phase 2CompletedUniversity of Washington232004-12-012008-09-19
Male Hormonal Contraceptive Development-ACY-5
Acyline, Testosterone Gel, Depo-Medroxyprogesterone - Contraception
Phase 1 / Phase 2CompletedUniversity of Washington432004-05-012008-09-19

Conditions studied

Breast Feeding (2)  ·  HIV Infections (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Bone Demineralization, Pathologic (1)  ·  Bone Diseases, Metabolic (1)  ·  Depression, Postpartum (1)  ·  Endometriosis (1)  ·  Tuberculosis (1)

Sponsors

FHI 360 (3)  ·  University of Washington (3)  ·  Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (2)  ·  Beatrice Chen (1)  ·  Boston University (1)  ·  Centers for Disease Control and Prevention (1)  ·  Emory University (1)  ·  King Chulalongkorn Memorial Hospital (1)  ·  MU-JHU CARE (1)  ·  Oregon Health and Science University (1)  ·  Sharon Achilles (1)  ·  St Stephens Aids Trust (1)  ·  University of California, San Diego (1)  ·  University of Pittsburgh (1)  ·  Women and Infants Hospital of Rhode Island (1)

Countries

United States (9)  ·  Kenya (2)  ·  Malawi (2)  ·  South Africa (2)  ·  Uganda (2)  ·  Zimbabwe (2)  ·  Botswana (1)  ·  Eswatini (1)  ·  Nepal (1)  ·  Pakistan (1)  ·  Puerto Rico (1)  ·  Thailand (1)  ·  United Kingdom (1)  ·  Zambia (1)

Top investigators

Alison Edelman, MD (1)  ·  Amneris E Luque, M.D. (1)  ·  Athena P Kourtis, MD, PhD, MPH (1)  ·  David Hubacher, PhD (1)  ·  Dawn S Chin-Quee, PhD, MPH (1)  ·  Felix Mhlanga, MD (1)  ·  Flavia Kiweewa Matovu, MBChB, MSc (1)  ·  Jennifer Robinson, MD, MPH (1)  ·  Jennifer Tang, MD, MSCR (1)  ·  Jessica Tarleton, MD, MPH (1)  ·  Lameck Chinula, MD (1)  ·  Lisa Haddad, MD (1)  ·  Renee Heffron, PhD, MPH (1)  ·  Rosie Mngqibisa, MBChB, MPH (1)  ·  Sam Phiri, PhD (1)

Results publications

PMID 17494097, PMID 16940442, PMID 17303493, PMID 24028749, PMID 25481376, PMID 25624326, PMID 29470950, PMID 29746813, PMID 29920171, PMID 31204114, PMID 31374188, PMID 31504342, PMID 32396700, PMID 32533883, PMID 33898953, PMID 34126052, PMID 34369424, PMID 34910143, PMID 35263421, PMID 35657948, PMID 35669313, PMID 35941737, PMID 35972853, PMID 36622252, PMID 36892945, PMID 38459552, PMID 39085989, PMID 39630076

NIH funding

U54HD042454 (2), K01TW009657 (1), R01HD089843 (1), U01AI068636 (1), U48DP001944 (1), UM1AI068636 (1)